Kunkel Lori Anne bought ELVN

October 30, 2026 · Form 4 insider transaction

Kunkel Lori Anne bought 3,741 shares of Enliven Therapeutics, Inc. at $1.12 per share, a transaction worth $4.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.